Related references
Note: Only part of the references are listed.Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer
Daniel Brungs et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer
Katsutoshi Shoda et al.
GASTRIC CANCER (2017)
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Simon Pernot et al.
EUROPEAN JOURNAL OF CANCER (2017)
The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions
Irena Meistere et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
Jing Gao et al.
CANCER SCIENCE (2017)
Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer
Isamu Hoshino et al.
CANCER SCIENCE (2017)
Functional Studies on Viable Circulating Tumor Cells
Klaus Pantel et al.
CLINICAL CHEMISTRY (2016)
The biology of circulating tumor cells
K. Pantel et al.
ONCOGENE (2016)
Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
Yilin Li et al.
BRITISH JOURNAL OF CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study
Didier Meulendijks et al.
CANCER (2016)
Clinical significance of circulating plasma DNA in gastric cancer
Wen-Liang Fang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Long-term prognostic impact of circulating tumour cells in gastric cancer patients
Hiroaki Ito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer
Simone Werner et al.
SCIENTIFIC REPORTS (2016)
Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer
H. Okabe et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Prognostic value of circulating CD133+ cells in patients with gastric cancer
Pu Xia et al.
CELL PROLIFERATION (2015)
Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay
Catherine Alix-Panabieres et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas
Ilja Kubisch et al.
ONCOLOGY (2015)
Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response
Ting-Ting Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Monitoring gastric cancer progression with circulating tumour DNA
T. Hamakawa et al.
BRITISH JOURNAL OF CANCER (2015)
Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma
S. L. Zhou et al.
DISEASES OF THE ESOPHAGUS (2015)
HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study
Katsutoshi Shoda et al.
GASTRIC CANCER (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer
Su Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
The quantification of HER2 and MYC gene fragments in cell-free plasma as putative biomarkers for gastric cancer diagnosis
Kyoung Un Park et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
A Pilot Study Assessing the Incidence and Clinical Significance of Circulating Tumor Cells in Esophagogastric Cancers
Francesco Sclafani et al.
CLINICAL COLORECTAL CANCER (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
Kyongchol Kim et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Clinical Significance of Circulating Tumor Cells in Peripheral Blood From Patients With Gastric Cancer
Yoshikazu Uenosono et al.
CANCER (2013)
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Yibin Kang et al.
CANCER CELL (2013)
Tumor-associated autoantibody signature for the early detection of gastric cancer
Pawel Zayakin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
Ellen Heitzer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The metastasis-promoting roles of tumor-associated immune cells
Heath A. Smith et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
Zhi-Qiang Ling et al.
PLOS ONE (2013)
Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study
Hiroaki Ito et al.
BMC CANCER (2012)
An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer
Qing-Wen Xu et al.
CANCER RESEARCH (2012)
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Manuel Valladares-Ayerbes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
Catalina Trejo-Becerril et al.
PLOS ONE (2012)
Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients
Jong-Lyul Park et al.
ONCOLOGY LETTERS (2012)
B7-H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells
Takaaki Arigami et al.
CANCER SCIENCE (2011)
Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis
Yanan Zheng et al.
CLINICAL BIOCHEMISTRY (2011)
Using Detection of Survivin-Expressing Circulating Tumor Cells in Peripheral Blood to Predict Tumor Recurrence Following Curative Resection of Gastric Cancer
Weiguo Cao et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Quantitative Analysis and Diagnostic Significance of Methylated SLC19A3 DNA in the Plasma of Breast and Gastric Cancer Patients
Enders K. O. Ng et al.
PLOS ONE (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Predictive Value of Serum CEA, CA19-9 and CA72.4 in Early Diagnosis of Recurrence after Radical Resection of Gastric Cancer
Yan Li et al.
HEPATO-GASTROENTEROLOGY (2011)
Prognostic Significance of E-cadherin Expression and Peripheral Blood Micrometastasis in Gastric Carcinoma Patients
Abeer A. Saad et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
Satoshi Matsusaka et al.
CANCER SCIENCE (2010)
Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma
Miao-zhen Qiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Circulating tumour cells in cancer patients: challenges and perspectives
Klaus Pantel et al.
TRENDS IN MOLECULAR MEDICINE (2010)
MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis
Kyoung Un Park et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Chemokines and chemokine receptors: an overview
Raffaella Bonecchi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival
Loris Bertazza et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse
Shang-mian Yie et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases
Koshi Mimori et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
Kunihiko Hiraiwa et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Reprimo as a Potential Biomarker for Early Detection in Gastric Cancer
Carolina Bernal et al.
CLINICAL CANCER RESEARCH (2008)
Autoantibodies in breast cancer: their use as an aid to early diagnosis
C. Chapman et al.
ANNALS OF ONCOLOGY (2007)
Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers
Chan-Hang Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma
YH Uen et al.
CLINICA CHIMICA ACTA (2006)
Clinical outcomes with Laparoscopic stage M1, unresected gastric adenocarcinoma
AI Sarela et al.
ANNALS OF SURGERY (2006)
Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: Evaluation of their prognostic significance
C. H. Wu et al.
DISEASE MARKERS (2006)
Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis
B Illert et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Circulating tumor cells in breast cancer:: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity
V Müller et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma
J Friederichs et al.
WORLD JOURNAL OF SURGERY (2005)
Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer
JH Seo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Apoptosis of circulating tumor cells in prostate cancer patients
CJ Larson et al.
CYTOMETRY PART A (2004)
Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer
S Sumikura et al.
CANCER LETTERS (2003)
Multiple pathways to tumor immunity and concomitant autoimmunity
MJ Turk et al.
IMMUNOLOGICAL REVIEWS (2002)
Analysis of the B-cell repertoire against antigens expressed by human neoplasms
KD Preuss et al.
IMMUNOLOGICAL REVIEWS (2002)
Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies
JY Zhang et al.
CLINICAL IMMUNOLOGY (2001)
Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery
F Miyazono et al.
ANNALS OF SURGERY (2001)
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer
S Ishigami et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Share Paper
